On International Women’s Day, Sakra Premium Clinic by Sakra World Hospital, one of Bangalore's premier healthcare organisations that boasts of Japanese cutting-edge technology delivering breakthrough healthcare in India, is set to launch ‘Sakra Women Care Centre’ in Sarjapur Road, Bangalore. Aimed at providing an integrated approach of both traditional healthcare and focusing on overall wellness of women, this new centre will comprehensively address the different aspects

Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio Pharmaceuticals drug, razuprotafib. Razuprotafib was chosen for testing in the I-SPY COVID Trial because it is hypothesized to stabilize and repair the blood vessels in the lung and improve gas exchange. The I-SPY COVID Trial is a Phase II adaptive platform trial that is testing agents that show promise for reducing the risk of death from and severi

Second Sight Medical Products a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced U.S. Food and Drug Administration (FDA) has approved the Argus 2s Retinal Prosthesis System, a redesigned set of external hardware (glasses and video processing unit) initially for use in combination with previously implanted Argus II systems for the treatment of retinitis pigmentosa (RP). The Co

Sight Sciences, Inc., a growth-stage medical device company focused on addressing the underlying causes of the world's most prevalent eye conditions, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the OMNI® Surgical System (OMNI) for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure (IOP) in adult patients with primary open&ndas

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the company has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate use of the BioSticker™ medical wearable device and data services in clinical trials of hematological cancer patients.   The BioSticker is the first FDA-cleared single-use medical device that enables 30 days of continuous vital signs monitoring. The BioInte

Spinal Elements, a spine technology company, today announced the relaunch and first clinical use of the Luna® XD multi-expandable lumbar interbody fusion device and Orbit® articulating discectomy system. A minimally-invasive transforaminal lumbar interbody fusion (TLIF) surgery was performed with the devices by Richard G. Fessler, M.D., Ph.D of Rush University Medical Group, Chicago, IL. “I am very pleased to be using both Orbit and Luna XD in my MIS TLIF procedures ag

Asensus Surgical, Inc. (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. Asensus Surgical's technology platform, Senhance® Surgical System, is the first of its kind dig

TheraCell Inc., a leading allograft solution company, today announced that its newest procedure-specific fiber graft form, the TheraFuze DBF Fiber Bag, is now available for use in spinal and orthopedic surgeries, including minimally invasive procedures. Additionally, the company announced that a patent (U.S. Patent Number 10,639,157) related to the Fiber Bag was issued by the United States Patent and Trademark Office in May 2020. The TheraFuze DBF Fiber Bag is a 100% allograft tissu

Guardant Health, Inc. has CE-marked Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any solid malignant neoplasm (cancerous tumor). The test is also approved as a companion diagnostic to identify non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) alterations who may benefit from treatment with Tagrisso® (osimertinib). The Guardant360 CDx test offers patients and clinicians a si

Kindred Healthcare, LLC and Texas Health Resources today announced they have acquired Everest Rehabilitation Hospital of Keller. The hospital, now renamed Texas Rehabilitation Hospital of Keller, will be operated through an existing joint venture between Kindred and Texas Health Resources. Texas Rehabilitation Hospital of Keller, which opened in December 2020, is a 36-bed rehabilitation hospital located in the northern suburbs of Fort Worth at 791 S. Main St., Keller, Texas.